Synlogic (SYBX) Tops Q3 EPS by 9c

Go back to Synlogic (SYBX) Tops Q3 EPS by 9c

Synlogic Provides Program and Business Update and Reports Third Quarter 2019 Financial Results

November 12, 2019 4:02 PM EST

SYNB1618 solid oral bridging study ongoing and SYNB1891 immuno-oncology study open

Company ends 3Q2019 with approximately $139 million in cash, cash equivalents and investments supporting projected runway through 2021

Management to host conference call and webcast at 5:00 pm ET today

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Synlogic, Inc. (Nasdaq: SYBX), a clinical... More